Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers
Background Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of many malignant tumors. However, ICI-induced hyper-immune activation causes cardiotoxicity. Traditional treatments such as glucocorticoids and immunosuppressants have limited effectiveness and may even accelerate tumo...
Saved in:
Main Authors: | Ping Li, Zhen Qin, Yang Lu, Jiamin Gao, Zhenwei Wang, Ge Zhang, Han Yang, Yachen Hou, Dashuai Wang, Pengchong Du, Yunzhe Wang, Quanzhou Chen, Zhaowei Sun, Jinying Zhang, Junnan Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/13/1/e010127.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation
by: Ruiping Cao, et al.
Published: (2019-01-01) -
Corrigendum to “ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation”
by: Ruiping Cao, et al.
Published: (2021-01-01) -
NLRP3 Inflammasome Simultaneously Involved in Autophagy and Phagocytosis of THP-1 Cells to Clear Aged Erythrocytes
by: Qin Li, et al.
Published: (2022-01-01) -
NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01) -
Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
by: Keren Zhou, et al.
Published: (2016-01-01)